Roche’s Evrysdi tablet receives US FDA approval for the treatment of spinal muscular atrophy: Basel Friday, February 14, 2025, 13:00 Hrs [IST] Roche, announced that the US Food ...
The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...
Mia Cassella told Newsweek: "Cancer might take away things like my hair or my energy, but it couldn't take away my passion for lifting and working out." ...
Story Jan. 13 - Apellis Pharmaceuticals: As it prioritizes commercializing geographic atrophy treatment Syfovre in the U.S., Apellis is cutting about 40 non-U.S. employees. Release Jan 10 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback